Parkinson’s disease Nervous System Diseases Parkinson disease
Conditions
Interventions
Participants are randomized according to the stratified randomization method of Vickers. Participants are stratified into two types, that is, E group and C group. For each type, the Random Number Gene
Sponsors
South Baylo University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosed with idiopathic PD based on UK Parkinson’s Disease Society Brain Bank criteria 2. Taking anti-Parkinson medications which remained unchanged until the end of this study
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured prior to the first treatment, after twelfth treatment, and one month after treatment: 1. Nonmotor symptoms measured using Unified Parkinson’s Disease Rating Scale (UPDRS) 2. Olfactory function measured using Test of Smell Identification (TSI) | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
United States of America
Outcome results
None listed